MUC1 and prostate carcinoma: To determine whether MUC1 from PC3 cells carries poly-N-acetyllactosamine on its O-glycans, we first excluded N-glycans from prostate cancer cells by treatment with tunicamycin, an N-glycosylation inhibitor, and then analyzed the cell lysates by immunoprecipitation using LEL.